# Clene (NASDAQ: CLNN) Presents Recent Achievements at H.C. Wainwright Conference

* The H.C. Wainwright 26th Annual Global Investment Conference is being held on-line and in person, Sept. 9-11.
* Clene management will give a virtual presentation of the company’s most recent achievements and results and will hold one-on-one investor meetings.
* Lead drug candidate CNM-Au8 has been shown to restore and protect neurological function, offering new hope for patients with neurodegenerative conditions.
* The company is seeking FDA approval to file a new drug application for CNM-Au8, using the accelerated approval pathway for treatment of ALS.

 Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), will present at the H.C. Wainwright 26th Annual Global Investment Conference.

 During the Sept. 9-11 event, Clene management presented the company’s latest achievements and updates, including recent results and plans for lead candidate CNM-Au8. The company will also participate in one-on-one investor meetings. A webcast of the presentation is available with…

 Read More>>

 OTE TO INVESTORS: IBN is a multifaceted financial news, content creation and publishing company utilized by both public and private companies to optimize investor awareness and recognition. For more information, please visit https://www.InvestorBrandNetwork.com

 Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

 The latest news and updates relating to CLNN are available in the company’s newsroom at https://ibn.fm/CLNN

 Corporate Communications

 IBN (InvestorBrandNetwork)Los Angeles, Californiawww.InvestorBrandNetwork.com310.299.1717 OfficeEditor@InvestorBrandNetwork.com 

---

[Original/Source Press Release](https://rss.investorbrandnetwork.com/ult-prem/clene-nasdaq-clnn-presents-recent-achievements-at-h-c-wainwright-conference/)
                    

[Newsramp.com TLDR](https://newsramp.com/curated-news/clene-to-present-at-h-c-wainwright-26th-annual-global-investment-conference/05b8fcec9c8f086ea4bb3530f56c5a4e) 


Pickup - [citybuzz.co](https://citybuzz.co/2024/09/12/clene-showcases-latest-advancements-in-neurodegenerative-disease-treatment-at-h-c-wainwright-conference)

Pickup - [fishervista.com](https://fishervista.com/en/clene-showcases-promising-neurodegenerative-disease-treatment-at-h-c-wainwright-conference/20246791)

Pickup - [newsworthy.ai](https://newsworthy.ai/curated/clene-showcases-promising-neurodegenerative-disease-treatment-at-h-c-wainwright-conference/20246791)

Pickup - [advos.io](https://advos.io/en/clene-showcases-cnm-au8-progress-at-h-c-wainwright-investment-conference/20246791)
 



[Reddit Post](https://www.reddit.com/r/Business_NewsRamp/comments/1ff2xx6/clene_to_present_at_hc_wainwright_26th_annual/) 



![Blockchain Registration](https://cdn.newsramp.app/ibn/qrcode/249/12/noraHvDD.webp)